节点文献

新辅助放化疗后临床完全缓解的直肠癌患者采用“等待观察”策略的安全性Meta分析

Meta-analysis of safety of "Wait and See" strategy for rectal cancer patients with clinical complete response after neoadjuvant chemoradiotherapy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 张旋代行龙周海张策雷青沈正海林艳苹李梅高屹

【Author】 ZHANG Xuan;DAI Xinglong;ZHOU Hai;ZHANG Ce;LEI Qing;SHEN Zhenghai;LIN Yanping;LI Mei;Gao Yi;Department of Colorectal Cancer Surgery Tumor Hospital of Yunnan Province/the Third Affiliated Hospital of Kunming Medical University;Department of Gastrointestinal Surgery the First Affiliated Hospital of Chongqing Medical University;Office of Cancer Center Tumor Hospital of Yunnan Province/the Third Affiliated Hospital of Kunming Medical University;Department of Thoracic Surgery Tumor Hospital of Yunnan Province/the Third Affiliated Hospital of Kunming Medical University;Department of Integrated Chinese and Western Medicines Tumor Hospital of Yunnan Province/the Third Affiliated Hospital of Kunming Medical University;

【通讯作者】 高屹;

【机构】 云南省肿瘤医院/昆明医科大学第三附属医院结直肠外科重庆医科大学第一附属医院胃肠外科云南省肿瘤医院/昆明医科大学第三附属医院癌症中心办公室云南省肿瘤医院/昆明医科大学第三附属医院胸外科云南省肿瘤医院/昆明医科大学第三附属医院中西医结合科

【摘要】 目的:评价直肠癌患者新辅助放化疗(NCRT)后达到临床完全缓解(cCR)采取"等待观察"(W&S)策略的安全性。方法:检索多个国外数据库并收集比较直肠癌患者NCRT后达到cCR采用W&S策略与根治性手术(RS)的临床研究。按纳入标准筛选文献、提取资料并进行文献质量评价,采用Stata/SE12.0统计软件对局部复发(LR)、远处转移(DM)、肿瘤相关死亡(CRD)、无疾病进展生存期(DFS)和总体生存期(OS)等指标进行Meta分析。结果:总共纳入11篇文献,均为中-高质量文献;共计直肠癌患者847例,其中W&S组378例,RS组469例。Meta分析结果显示,W&S组LR(RR=6.20,95%CI=2.68~14.30,P=0.000),2年OS(RR=1.05,95%CI=1.01~1.10,P=0.029)及3年OS(RR=1.09,95%CI=1.03~1.15,P=0.004)方面明显优于RS组,而两组在DM,CRD,2、3、5年DFS及5年OS方面差异无统计学意义(均P>0.05)。结论:对于部分NCRT后达到cCR的直肠患者采用W&S策略是安全可行的,但需制定严格的筛选标准以及规范的随访体系。亟待未来的大样本、多中心、前瞻性随机对照研究对W&S策略加以验证。

【Abstract】 Objective: To evaluate the safety of applying the "Wait-and-See"(W&S) strategy in rectal cancer patients with clinical complete response(cCR) after neoadjuvant chemoradiotherapy(NCRT). Methods: The clinical studies comparing using W&S strategy and radical surgery(RS) in rectal cancer patients with cCR after NCRT were collected by searching several foreign databases. After screening for inclusion, data extraction and quality assessment, Meta-analysis was performed on the variables that included local recurrence(LR), distant metastasis(DM), cancer-related death(CRD), disease-free survival(DFS) and overall survival(OS) by using Stata/SE 12.0 software.Results: Eleven studies with moderate to high quality were included, involving 847 patients, with 378 cases in W&S group and 469 cases in RS group. The results of Meta-analysis showed that W&S group was superior to RS group in terms of LR(RR=6.20, 95% CI=2.68–14.30, P=0.000), 2-year OS(RR=1.05, 95% CI=1.01–1.10, P=0.029) and 3-year OS(RR=1.09, 95% CI=1.03–1.15, P=0.004), while no differences were noted with regard to DM, CRD, or 2-, 3-and 5-year DFS as well as 5-year OS between the two groups(all P>0.05). Conclusion: W&S strategy is safe and feasible for some patients who achieved cCR after NCRT, but this strategy requires rigorous screening criteria and standardized follow-up program. Meanwhile, large sample size and multicentric, prospective randomized controlled trials are urgently expected to verify this treatment approach.

【基金】 国家自然科学基金资助项目(81560472);国家卫计委医药卫生科技发展基金资助项目(W2017ZWS09)
  • 【文献出处】 中国普通外科杂志 ,Chinese Journal of General Surgery , 编辑部邮箱 ,2018年10期
  • 【分类号】R735.37
  • 【被引频次】5
  • 【下载频次】217
节点文献中: 

本文链接的文献网络图示:

本文的引文网络